Understanding Mouse Bladder Responses to BCG Treatment
Author Information
Author(s): Saban Marcia R, O'Donnell Michael A, Hurst Robert E, Wu Xue-Ru, Simpson Cindy, Dozmorov Igor, Davis Carole, Saban Ricardo
Primary Institution: Oklahoma University Health Sciences Center
Hypothesis
Does Bacillus Calmette-Guerin (BCG) alter gene expression in the bladder beyond its pro-inflammatory effects?
Conclusion
BCG treatment induces unique gene expression related to immune and nervous system development in the bladder.
Supporting Evidence
- BCG treatment leads to the transcription of genes involved in immune responses.
- Unique gene networks related to axonal guidance and lymphatic system development were identified.
- NF-kappaB plays a significant role in bladder responses to BCG therapy.
Takeaway
This study shows that BCG, a treatment for bladder cancer, not only causes inflammation but also changes how certain genes work in the bladder.
Methodology
C57BL/6 female mice received four weekly instillations of BCG, LPS, or TNF-α, followed by RNA extraction and microarray analysis.
Limitations
The study was conducted at a single time point, which may not capture the full range of responses over time.
Participant Demographics
C57BL/6 female mice, aged 10-12 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website